CLINICAL TRIALS
Signs and symptoms of Alzheimer’s disease We all experience memory issues from time to time. But experiencing the following more and more often may be an early sign of Alzheimer’s…
CONDITION: Neurological
TRIAL STATUS: Recruiting
GENDER: Both males and females
AGE GROUP: 50 years to 90 years
Background Depression is a serious and disabling illness that affects millions of people every year. Many of those struggling with depression feel that currently available antidepressants have not adequately treated…
CONDITION: Mental Health
TRIAL STATUS: Recruiting
GENDER: Both males and females
AGE GROUP: 18 years to 70 years
Australian researchers are testing a new medication for idiopathic pulmonary fibrosis. This is a 60 day study with 10 separate visits. You will be treated at no cost, and most…
CONDITION: Respiratory
TRIAL STATUS: Recruiting
GENDER: Both males and females
AGE GROUP: 40 years to 80 years
Title: A non-interventional, prospective 12 months study to characterize the REAL-life effectiveness and treatment patterns of Secukinumab and current standard of care in patient with chronic plaque psoriAsis eligible for…
CONDITION: Skin
TRIAL STATUS: Active, not recruiting
GENDER: Both males and females
AGE GROUP: 18 years and above
Australian researchers are testing a new oral medication for severe asthma. This is a 52 week study with 11 separate visits and 6 telephone calls. You will be treated at…
CONDITION: Respiratory
TRIAL STATUS: Recruiting
GENDER: Both males and females
AGE GROUP: 12 years and above
Australian researchers are testing a potential new treatment for type 2 diabetes mellitus. They are looking for volunteers to participate in this study, which includes up to 4 separate clinic…
CONDITION: Metabolic and Endocrine
TRIAL STATUS: Recruiting
GENDER: Both males and females
AGE GROUP: 20 years to 80 years
Footwear for self-managing knee osteoarthritis symptoms– volunteers needed! Researchers from the Centre for Health, Exercise and Sports Medicine at The University of Melbourne are conducting a research study to compare two…
CONDITION: Musculoskeletal
TRIAL STATUS: Recruiting
GENDER: Both males and females
AGE GROUP: 50 years and above
This project will specifically compare the effects of two different exercise programs for individuals with knee osteoarthritis who have higher body weights and evaluate if they respond differently to either…
CONDITION: Musculoskeletal
TRIAL STATUS: Recruiting
GENDER: Both males and females
AGE GROUP: 50 years and above
This is a 12 week study to test two herbal supplements (Trigonella foenum-graecum Seed Extract and Coccinia Grandis Extract)for Normalizing Elevated (pre-diabetic) Blood Glucose and improving Insulin Sensitivity. It is being conducted in Brisbane…
CONDITION: Metabolic and Endocrine
TRIAL STATUS: Recruiting
GENDER: Both males and females
AGE GROUP: 18 years to 70 years
Attention Deficit Hyperactivity Disorder (ADHD) is a common behavioural condition that affects thousands of children and families in Australia. ADHD is a complex disorder involving difficulties with hyperactivity, concentration and…
CONDITION: Other
TRIAL STATUS: Recruiting
GENDER: Both males and females
AGE GROUP: 6 years to 17 years
A 26 Week, Multicenter, Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase 3 Trial With a 26 Week Safety Extension Period Evaluating the Safety and Efficacy of Dapagliflozin 5 and 10 mg,…
CONDITION: Metabolic and Endocrine
TRIAL STATUS: Recruiting
GENDER: Both males and females
AGE GROUP: 10 years to 18 years
A Randomized, Double-blind, Placebo-controlled, Multi-center Study to Assess the Safety and Efficacy of Different Oral Doses of BAY94-8862 in Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of…
CONDITION: Metabolic and Endocrine
TRIAL STATUS: Recruiting
GENDER: Both males and females
AGE GROUP: 18 years and above
The use of NOX66 as a tumour cell-specific sensitiser of radiation therapy may provide greater response to targeted radiation therapy within the tumour cells, with the tumour specific nature of…
CONDITION: Cancer
TRIAL STATUS: Recruiting
GENDER: Males
AGE GROUP: 18 years
Researchers at QBI are looking for participants diagnosed with treatment-resistant Obsessive-Compulsive Disorder (OCD). If you are you between 18 and 70 years of age and live within reasonable travelling distance…
CONDITION: Mental Health
TRIAL STATUS: Recruiting
GENDER: Both males and females
AGE GROUP: 18 years to 70 years
If you or someone you know has been diagnosed with cluster headaches, a clinical research study may be an option. Wesley Medical Research are looking for people who are…
CONDITION: Neurological
TRIAL STATUS: Recruiting
GENDER: Both males and females
AGE GROUP: 18 years to 70 years
An NHMRC funded clinical trial investigating the effects of a herbal medicine extract called Kava for individuals with Generalised Anxiety Disorder (GAD). The KGAD study is an 18-week, double blind,…
CONDITION: Mental Health
TRIAL STATUS: Closed: follow-up continuing
GENDER: Both males and females
AGE GROUP: 18 years to 70 years
Researchers are trialling an investigational medication for the potential treatment of Plaque Psoriasis. By participating in this study you will help to obtain important information about whether this investigational medication…
CONDITION: Skin
TRIAL STATUS: Closed: follow-up complete
GENDER: Both males and females
AGE GROUP: 18 years to 75 years
A 24-week, double blind placebo study investigating the effects of the amino acid ‘N-acetylcysteine’ (NAC) in Obsessive-Compulsive Disorder (OCD). This study will determine if NAC is an effective treatment for…
CONDITION: Mental Health
TRIAL STATUS: Recruiting
GENDER: Both males and females
AGE GROUP: 18 years to 75 years
ARE YOU: A pre-diabetic OR type 2 diabetic (diet-controlled or taking Metformin only) Aged between 18 and 70 years Someone with no significant weight change in the last 6 months…
CONDITION: Metabolic and Endocrine
TRIAL STATUS: Recruiting
GENDER: Both males and females
AGE GROUP: 18 years to 70 years
This trial is designed to evaluate the safety, tolerability, and preliminary efficacy of intra-tumour injections of SD-101 in combination with intravenous Keytruda (pembrolizumab) in patients with metastatic melanoma. Patients can have progressed…
CONDITION: Cancer
TRIAL STATUS: Recruiting
GENDER: Both males and females
AGE GROUP: 18 years to 70 years
Previous Page Next Page